Clarke Valve Closes $5.5 Million Venture Funding Round Led by OGCI Climate Investments
Clarke Valve today completed the sale of $5.5 million of Series B Preferred Stock to a group of investors led by OGCI Climate Investments. Along with funding from Saudi Aramco Energy Ventures and Chevron Technology Ventures, Clarke has now raised $15.5 million of Series B funding.
Clarke’s patented Shutter Valves are typically 1/5th the weight, 1/5th the size and 1/5th the cost of equivalent legacy valves, providing substantial benefits to users of industrial control valves in many industries. In addition, Clarke valves are currently the only control valves in the world to achieve the stringent American Petroleum Institute (API) 641 certification for low fugitive emission performance. Fugitive emissions from legacy valve designs is the cause of significant methane emitted to the atmosphere from industrial facilities.
Pratima Rangarajan, CEO of OGCI Climate Investments, said “We are pleased to support the Clarke team in its journey to reach a global market. We believe that the Clarke Valve technology can address fugitive methane emissions in a meaningful way.”
Kyle Daniels, President & CEO of Clarke Valve said, "While our goal has always been to produce the world’s best performing valve, an equally important goal is to minimize methane emissions. This new funding will enable Clarke to roll out its proprietary solution for reducing fugitive emissions and provide a retrofit solution for the majority of competitive valves in the marketplace. The support of OGCI Climate Investments means our leading-edge technology will gain further visibility, helping us to capture market share and reduce fugitive methane emissions from legacy valve designs.”
Bill Dambrackas, Chairman of Clarke Valve, said, "Clarke has now raised over $23 million from investors, many of which are affiliated with oil & gas companies that are among the world's leading valve users and valve experts. Their choice to invest in Clarke Valve is a big vote of confidence in validating our vision. Also, many of our previous and original investors participated in this round, including New World Angels (NWA) and Ocean Azul. We continue to appreciate their support and we join them, along with Saudi Aramco Energy Ventures and Chevron Technology Ventures in welcoming OGCI Climate Investments to our team.”
About OGCI Climate Investments
OGCI Climate Investments LLP is a billion-dollar investment fund focused on initiating practical actions to deliver solutions for a sustainable, low-emissions future. The fund invests in technologies that have the potential to significantly reduce greenhouse gas emissions, are economically viable, ready to be commercialized, and deployed at scale. It was launched in November 2016 by the Oil and Gas Climate Initiative, a voluntary initiative led by CEOs of 13 global oil and gas companies. For more information, please visit www.oilandgasclimateinitiative.com.
About Clarke Valve
Clarke Valve is an innovative valve design & manufacturing company disrupting the industrial flow control market, utilizing advanced aerospace design techniques. The Shutter Valve is a full-bore control valve that virtually eliminates fugitive emissions. Our innovative design provides ideal attributes for industrial control valves, including unsurpassed flow rate, zero pressure drop, zero leakage, and reduced cavitation & pitting, resulting in improved wear/maintenance characteristics and precise flow control. The Company’s standard products are engineered to meet customer needs and are assembled at our headquarters in Rhode Island. For more information, please visit www.clarkevalve.com.
©2018 Clarke Valve. All rights reserved. Clarke Valve and Shutter Valve are trademarks of Clarke Valve and may be registered in the U.S. Patent and Trademark Office. All other trademarks and registered trademarks are the property of their respective owners.
Mark Kacer, 401-667-7880
Chief Operating Officer
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
SmartStream Steps Ahead with New Industry Digital Payments Solution22.10.2018 23:01 | Pressemelding
SmartStream Technologies, the financial Transaction Lifecycle Management (TLM®) solutions provider, today announced the launch of TLM Aurora, the next generation of Corona, the industry’s leading reconciliation platform – the first new module is designed to support the new industry standards in the digital payments world, by providing connectors to SWIFT GPI, RTGS, as well as Blockchain based networks, allowing for real-time operational control, proactive exception management and low TCO. TLM Aurora provides the new generation of integrated operational control for the digital marketplace. As transactions increase in variability, velocity and volume, the need for scalable, real-time, integrated reconciliations is greater than ever. TLM Aurora supports organisations in performing operations such as SWIFT and SEPA transfers, mobile, cash and card payments, digital currencies, settlements and reconciliations. The solution is agile enough to support the smallest of organisations and can be
CoreLogic to Acquire Symbility Solutions Inc.22.10.2018 22:12 | Pressemelding
CoreLogic (NYSE: CLGX), a leading global provider of property information, insight, analytics and data-enabled solutions, today announced the Company has entered into a definitive agreement to acquire the outstanding shares of Symbililty Solutions Inc. (“Symbility”) (TSX.V: SY) not already owned by CoreLogic. CoreLogic currently holds approximately a 28% ownership interest in Symbility. Symbility, founded in 2004, is a leading provider of subscription and cloud-based property insurance claims workflow solutions for the Property & Casualty insurance industry. Symbility also provides an extensive array of innovative enterprise mobile and application software solutions. The company is headquartered in Toronto, Canada and operates in the U.S., Canada, the United Kingdom, Germany, Netherlands, Australia and New Zealand. “Symbility expands our footprint in property and casualty insurance domestically and in key markets around the globe. Further scaling our insurance and international footpri
Pacific Drilling Awarded Contract for the Pacific Bora22.10.2018 21:00 | Pressemelding
Pacific Drilling S.A. (OTC: PACDQ) (“Pacific Drilling” or the “Company”) announced today that its deepwater drillship the Pacific Bora has been awarded a contract by Nigerian Agip Exploration Limited (a subsidiary of Eni SpA) for drilling operations in Nigeria. The term of the contract is for one firm well plus two additional option wells. The contract is expected to commence in mid to late November 2018 and firm contract backlog is estimated at $9 million. Pacific Drilling Chief Executive Officer Paul Reese commented: “On the heels of our previous announcement of new work for Pacific Santa Ana in Mauritania, we are pleased to have secured this contract for the Bora which reflects our substantial experience in Nigeria and our uninterrupted commitment to providing exceptional drilling services to our clients.” Currently offshore Abidjan, Côte d'Ivoire, the Pacific Bora is a sixth generation deepwater, dynamically-positioned drillship capable of operating in water depths up to 10,000 fee
ResMed Wins German Patent Infringement Case Against Fisher & Paykel22.10.2018 20:30 | Pressemelding
ResMed (NYSE: RMD) (ASX: RMD), the world’s leading tech-driven medical company and innovator in sleep apnea and respiratory care, today announced the results of a court and patent office ruling in Germany in ResMed’s favor. A trial court ruling from the Munich District Court states that the headgear used on two Fisher & Paykel CPAP masks – the Simplus full face and Eson 2 nasal mask – infringes ResMed patent EP 2 373 368 B1 in Germany. In a separate decision, the Opposition Division of the European Patent Office had already decided that the patent asserted against Fisher & Paykel is valid. Each decision may be appealed by Fisher & Paykel. “We applaud the Munich District Court for reaching this just finding, and are exploring all options in light of the fact that Fisher & Paykel is selling CPAP masks with headgear that infringes a valid ResMed patent in Germany,” said ResMed Chief Administrative Officer and Global General Counsel David Pendarvis. “We will continue to defend our intellec
Grand Prize Winner in $1.75M Water Abundance XPRIZE Announced at XPRIZE Visioneering 201822.10.2018 17:49 | Pressemelding
During Visioneering 2018, XPRIZE’s annual gathering of philanthropists and innovators to evaluate concepts for future competitions, the Foundation revealed the results of its latest, completed XPRIZE. The Skysource / Skywater Alliance was announced as the grand prize winner of the $1.75M Water Abundance XPRIZE, a two-year competition aimed at alleviating the global water crisis with energy-efficient technologies that harvest fresh water from thin air. In addition at Visioneering, five new prize concepts were evaluated with top honors going to a prize concept called “Coral Survival”, a prize designed to protect and restore coral reefs. This prize will move forward into the XPRIZE pipeline. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181022005795/en/ The Skysource / Skywater Alliance team, based in Venice Beach, California, wins the Water Abundance XPRIZE (Photo: Business Wire) The Water Abundance XPRIZE, powered by the Tat
Positive Trial Results with Filgotinib in Psoriatic Arthritis and Ankylosing Spondylitis Both Published in The Lancet22.10.2018 17:15 | Pressemelding
Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced that detailed results from two clinical trials evaluating filgotinib, an investigational, selective JAK1 inhibitor, for the treatment of psoriatic arthritis and ankylosing spondylitis were both published in The Lancet. The publication of the Phase 2 EQUATOR data also coincides with a plenary session presentation at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting. “The results of the EQUATOR and TORTUGA studies demonstrate that filgotinib improved the signs and symptoms of patients with psoriatic arthritis whose disease had not responded to prior therapies and independently, for those with ankylosing spondylitis,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “These findings represent an important step forward in our efforts to improve outcomes for people livin